I3LUNG: An EU-funded Project fostering the implementation of artificial intelligence (AI)-based personalized medical care for lung cancer patients.
For World Cancer Day we are excited to announce the website that exclusively houses information related to the I3LUNG project is live! Here, you will find everything you need to know about the study that is solving the puzzle of lung cancer complexity with artificial intelligence.
From 2022 to 2023 World Cancer Day is dedicated to Closing the Care Gap and ensuring that everyone has equal access to cancer care. The I3Lung Project aims to support this cause and was funded under the framework of “Ensuring access to innovative, sustainable, and high-quality healthcare.” Specifically, the project will utilize artificial intelligence and machine learning to develop a tool that will help patients created a tailored treatment. This tool, once finalized, will be accessible to patients globally and will not only help patients be more involved in the decision making but will also lead to more personalized treatment plans in lung cancer care.
As a reminder, this is an EU-Funded Project* where MEDSIR plays an important role as a Project Manager and Communication and Dissemination lead.
To help you navigate this website, below is an explanation of each section:
This section will give you all the information about who is involved in this cutting-edge project. Specifically, the consortium involves 16 different partners from the EU, Israel, and the United States. You can learn more about each one of them on this page!
This project is extensive, involving the worldwide expertise of the partners, and utilizes Artificial Intelligence to help provide a better treatment plan for each individual patient affected by metastatic lung cancer. In this section you can learn more about the specifics of the project, hear from Dr. Arsela Prelaj from Istituto Nazionale Tumori of Milan, the leader and Principal Investigator of this project, and understand the timeline of this initiative.
You’ll want to periodically check this section! Stay informed on the latest breakthroughs and discoveries in the scientific community. Here you'll find the most up-to-date news and research on a variety of topics, as well as expert analysis and commentary from some of the brightest minds in the field.
The project’s goal is to improve current treatment of metastatic non-small cell lung cancer by helping patients and their oncologists select the right therapeutic approach for each individual and move cancer treatment towards a more personalized approach. With 7 different languages to choose from on this page, it tailors the needs of our readers and especially our patients who are the heart of this project. It’s so important to us that they understand what we do for them!
If you have any questions, comments, or suggestions fill out the contact form in the CONTACT section or email the team at firstname.lastname@example.org! You can also follow the social networks on Facebook, Instagram, Twitter, and LinkedIn. The I3LUNG Consortium would love to hear from you!
Get inspired and stay on top of the latest developments with our innovative project! Our website is your go-to source for all things related to this cutting-edge initiative. We encourage you to bookmark us and check back often over the next 5 years to stay informed!
*Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be held responsible for them.